Tag Archives: diabetes

Apple reportedly tested a blood glucose monitoring app

Posted on by

Apple is reportedly still working on glucose management — this time through software. Bloomberg’s Mark Gurman says the company tested an app this year for pre-diabetic people, helping them manage their diet and lifestyle. Apple is said not to have plans to launch the app to consumers, but it could play a part in future health products.

The company reportedly tested the app internally, with employees confirmed through a blood test to be at risk of developing Type 2 diabetes. The subjects “actively monitored their blood sugar via various devices available on the market,” logging corresponding glucose changes. The app would then note correlations between dietary changes and blood sugar levels (for example, “don’t eat the pasta”).

Gurman says Apple paused the test to focus on other health features. Bloomberg notes that the Apple Health app currently lacks meal tracking, something rival services offer. The publication also says Apple could eventually offer deeper third-party glucose tracking integration into its products.

The study reportedly wasn’t directly related to Apple’s 15-year quest to offer non-invasive blood glucose monitoring, something that’s seemingly regurgitated in Apple Watch rumors every cycle. The company’s current hardware prototype is reportedly an iPhone-sized wearable device that uses lasers to shoot light into the skin. Gurman claims Apple’s first consumer-facing version — whether in the Apple Watch or some other form — will likely only notify users if they may be pre-diabetic. Providing specific glucose levels would have to come in later iterations.

This article originally appeared on Engadget at https://www.engadget.com/big-tech/apple-reportedly-tested-a-blood-glucose-monitoring-app-204241266.html?src=rss

Apple reportedly tested a blood glucose monitoring app

Posted on by

Apple is reportedly still working on glucose management — this time through software. Bloomberg’s Mark Gurman says the company tested an app this year for pre-diabetic people, helping them manage their diet and lifestyle. Apple is said not to have plans to launch the app to consumers, but it could play a part in future health products.

The company reportedly tested the app internally, with employees confirmed through a blood test to be at risk of developing Type 2 diabetes. The subjects “actively monitored their blood sugar via various devices available on the market,” logging corresponding glucose changes. The app would then note correlations between dietary changes and blood sugar levels (for example, “don’t eat the pasta”).

Gurman says Apple paused the test to focus on other health features. Bloomberg notes that the Apple Health app currently lacks meal tracking, something rival services offer. The publication also says Apple could eventually offer deeper third-party glucose tracking integration into its products.

The study reportedly wasn’t directly related to Apple’s 15-year quest to offer non-invasive blood glucose monitoring, something that’s seemingly regurgitated in Apple Watch rumors every cycle. The company’s current hardware prototype is reportedly an iPhone-sized wearable device that uses lasers to shoot light into the skin. Gurman claims Apple’s first consumer-facing version — whether in the Apple Watch or some other form — will likely only notify users if they may be pre-diabetic. Providing specific glucose levels would have to come in later iterations.

This article originally appeared on Engadget at https://www.engadget.com/big-tech/apple-reportedly-tested-a-blood-glucose-monitoring-app-204241266.html?src=rss

Glucose monitor and insulin pump concept is a sustainable way to keep tabs on diabetes

Posted on by

Of the many disorders that afflict people today, diabetes is perhaps the literally most painful one to monitor and maintain. Even with advancements in medical technology, pricking your finger is still the most accurate way to measure blood sugar levels. At the same time, taking in insulin often involves painful and tedious injections. And it isn’t just humans who are hurting from these, but the environment also suffers from all the waste these life-saving tools produce. It’s probably high time to have a glucose monitor and insulin delivery system that is not only painless and convenient but also sustainable, which is exactly what this minimalist-looking device concept is proposing.

Designer: Maxwell Stevens

CGMs or Continuous Glucose Monitors are one of the less invasive methods of keeping tabs on your blood sugar levels, though most do require inserting a sensor under the skin that is read by a device that sticks to your body over that site. When it comes to injecting insulin, on the other hand, insulin pumps remove the need to always pierce your skin for every injection, as a needle stays in its position for a day or two before needing to be replaced, unless the pump is one that actually stays on your body and above your skin. If these two devices sound almost related, it’s because they really are, and the Ingo CGM and insulin pump concept actually combines these two functions into a single, reusable, and sustainable device.

This oval-shaped device combines two critical functions in a single compact design that diabetes patients can discreetly wear on their bodies. Ingo can even have different colors to match skin tones so they won’t stand out as much as more obvious medical devices. There’s also the element of convenience as the device can be easily recharged on a wireless base, while the CGM sensor and pump needle are integrated into the sensor patches that stick over your skin.

Ingo also differs from existing CGMs and insulin pumps in the way that it tries to reduce the amount of waste as much as possible. Instead of disposable parts, it uses reusable components and recyclable patches, lessening the burden on the environment that these solutions often place on the planet. The rechargeable device and refillable insulin tank also prolong the life of the product or at least those parts that shouldn’t have to be thrown away frequently. Ingo is definitely an interesting proposal for a more humane and more environment-friendly way to keep diabetes patients living healthy and meaningful lives while also taking care of the planet they’re living on.

The post Glucose monitor and insulin pump concept is a sustainable way to keep tabs on diabetes first appeared on Yanko Design.

England’s NHS will provide artificial pancreas to thousands of diabetes patients

Posted on by

England’s National Health Service (NHS) said on Tuesday that “tens of thousands of children and adults” with type 1 diabetes will receive an “artificial pancreas” to help manage their insulin levels. The hybrid closed loop system — a sensor under the skin that sends wireless readings to an externally worn pump, which delivers insulin as needed — can help patients avoid the risks of type 1 diabetes without worrying about finger sticks or injections.

This isn’t the first device of its kind. Tandem makes similar insulin pumps in the US after it received FDA authorization in 2019. Gizmodo notes that another company called iLet got FDA approval for a similar device last year. Although the NHS hasn’t said which specific device(s) its program will use, what’s different here is the nation’s publicly funded health care system providing them for free rather than as an exclusive privilege for the well-to-do. (Sigh.)

The hybrid closed loop system starts with a sensor implanted beneath the skin, which continually monitors glucose levels at regular intervals. The sensor sends that data wirelessly to a pump, worn externally, which delivers the proper insulin dosage. The “hybrid” part of its name comes from the fact that some user input, including entering carb intake, is still required in the otherwise self-regulating system.

The government agency gave an ultra-precise figure of 269,095 people in England living with type 1 diabetes, highlighting how many folks could potentially benefit from the rollout. The NHS says local branches will begin identifying patients for the program starting on Tuesday.

“Diabetes is a tough and relentless condition, but these systems make a significant, life-changing difference — improving both the overall health and quality of life for people with diabetes,” Colette Marshall, chief executive of Diabetes UK, wrote in the NHS’s press release announcing the rollout. “This really is a landmark moment and we’ll be working with the NHS and others to ensure a fair rollout that reaches people as quickly as possible.”

This article originally appeared on Engadget at https://www.engadget.com/englands-nhs-will-provide-artificial-pancreas-to-thousands-of-diabetes-patients-203236067.html?src=rss

England’s NHS will provide artificial pancreas to thousands of diabetes patients

Posted on by

England’s National Health Service (NHS) said on Tuesday that “tens of thousands of children and adults” with type 1 diabetes will receive an “artificial pancreas” to help manage their insulin levels. The hybrid closed loop system — a sensor under the skin that sends wireless readings to an externally worn pump, which delivers insulin as needed — can help patients avoid the risks of type 1 diabetes without worrying about finger sticks or injections.

This isn’t the first device of its kind. Tandem makes similar insulin pumps in the US after it received FDA authorization in 2019. Gizmodo notes that another company called iLet got FDA approval for a similar device last year. Although the NHS hasn’t said which specific device(s) its program will use, what’s different here is the nation’s publicly funded health care system providing them for free rather than as an exclusive privilege for the well-to-do. (Sigh.)

The hybrid closed loop system starts with a sensor implanted beneath the skin, which continually monitors glucose levels at regular intervals. The sensor sends that data wirelessly to a pump, worn externally, which delivers the proper insulin dosage. The “hybrid” part of its name comes from the fact that some user input, including entering carb intake, is still required in the otherwise self-regulating system.

The government agency gave an ultra-precise figure of 269,095 people in England living with type 1 diabetes, highlighting how many folks could potentially benefit from the rollout. The NHS says local branches will begin identifying patients for the program starting on Tuesday.

“Diabetes is a tough and relentless condition, but these systems make a significant, life-changing difference — improving both the overall health and quality of life for people with diabetes,” Colette Marshall, chief executive of Diabetes UK, wrote in the NHS’s press release announcing the rollout. “This really is a landmark moment and we’ll be working with the NHS and others to ensure a fair rollout that reaches people as quickly as possible.”

This article originally appeared on Engadget at https://www.engadget.com/englands-nhs-will-provide-artificial-pancreas-to-thousands-of-diabetes-patients-203236067.html?src=rss

FDA approves the first over-the-counter continuous glucose monitor

Posted on by

The US Food and Drug Administration has approved the first continuous glucose monitor (CGM) people can buy without a prescription. Dexcom's Stelo Glucose Biosensor System has a sensor users are meant to insert into their upper arm, similar to the company's other CGMs that need a doctor's prescription for purchase. It pairs with a smartphone application that can show the user's blood glucose measurements and trends every 15 minutes. 

The company designed the device specifically for adults 18 and up who are not using insulin, such as those managing their diabetes with oral medications and non-diabetics making a conscious effort to control their sugar intake. It could be a great tool for people with insulin resistance, including individuals with PCOS and other metabolic issues that heighten their probability of developing diabetes in the future. In general, it could give users the insight to be able to better understand how the food they eat and the movements they make impact their overall health. 

While CGMs aren't anything new, they've become a wellness trend on social media last year, and even non-diabetics started using them. By clearing Stelo, the FDA is making the monitors more accessible than before. "CGMs can be a powerful tool to help monitor blood glucose," said Jeff Shuren, MD, director of the FDA's Center for Devices and Radiological Health. "Today's clearance expands access to these devices by allowing individuals to purchase a CGM without the involvement of a health care provide. Giving more individuals valuable information about their health, regardless of their access to a doctor or health insurance, is an important step forward in advancing health equity for U.S. patients."

Stelo will be available starting this summer. Each patch is meant to last for 15 days before users will need to replace it. Dexcom has yet to reveal how much it would cost, but it said Stelo will "provide an option for those who do not have insurance coverage for CGM."

A gray circular device.
Dexcom

This article originally appeared on Engadget at https://www.engadget.com/fda-approves-the-first-over-the-counter-continuous-glucose-monitor-130008629.html?src=rss

FDA approves the first over-the-counter continuous glucose monitor

Posted on by

The US Food and Drug Administration has approved the first continuous glucose monitor (CGM) people can buy without a prescription. Dexcom's Stelo Glucose Biosensor System has a sensor users are meant to insert into their upper arm, similar to the company's other CGMs that need a doctor's prescription for purchase. It pairs with a smartphone application that can show the user's blood glucose measurements and trends every 15 minutes. 

The company designed the device specifically for adults 18 and up who are not using insulin, such as those managing their diabetes with oral medications and non-diabetics making a conscious effort to control their sugar intake. It could be a great tool for people with insulin resistance, including individuals with PCOS and other metabolic issues that heighten their probability of developing diabetes in the future. In general, it could give users the insight to be able to better understand how the food they eat and the movements they make impact their overall health. 

While CGMs aren't anything new, they've become a wellness trend on social media last year, and even non-diabetics started using them. By clearing Stelo, the FDA is making the monitors more accessible than before. "CGMs can be a powerful tool to help monitor blood glucose," said Jeff Shuren, MD, director of the FDA's Center for Devices and Radiological Health. "Today's clearance expands access to these devices by allowing individuals to purchase a CGM without the involvement of a health care provide. Giving more individuals valuable information about their health, regardless of their access to a doctor or health insurance, is an important step forward in advancing health equity for U.S. patients."

Stelo will be available starting this summer. Each patch is meant to last for 15 days before users will need to replace it. Dexcom has yet to reveal how much it would cost, but it said Stelo will "provide an option for those who do not have insurance coverage for CGM."

A gray circular device.
Dexcom

This article originally appeared on Engadget at https://www.engadget.com/fda-approves-the-first-over-the-counter-continuous-glucose-monitor-130008629.html?src=rss